中国经济网北京12月9日讯 中证指数有限公司2025年11月28日发布关于沪深300、中证500、中证1000、中证A500等 指数定期调整结果的公告。根据指数规则，经指数专家委员会审议，中证指数有限公司决定调整沪深300、中证500、中 证1000、中证A50、中证A100、中证A500等指数样本，于2025年12月12日收市后生效。其中沪深300指数更换11只样 本，中证500指数更换50只样本，中证1000指数更换100只样本，中证A50指数更换4只样本，中证A100指数更换6只样 本，中证A500指数更换20只样本。 调整结果显示，三人行(605168.SH)被调出中证1000指数样本名单。 | 1 iF 1 | | --- | | # 11 1000 6 | | 教 ALL | | 18/ 博 | | : 7 - | | 政 调 1 10.000 | | 5 A 1 1 | | 日 . | | . 1 | 2020年5月28日，三人行在上交所主板上市，发行数量为1,726.60万股，发行价格为60.62元/股，保荐机构（主承销 商）为兴业证券股份有限公司，保荐代表人为张吉翔、谢雯。 三人行首次公开发 ...

中国经济网北京12月9日讯中证指数有限公司2025年11月28日发布关于沪深300、中证500、中证1000、中证A500等指数 定期调整结果的公告。根据指数规则，经指数专家委员会审议，中证指数有限公司决定调整沪深300、中证500、中证 1000、中证A50、中证A100、中证A500等指数样本，于2025年12月12日收市后生效。其中沪深300指数更换11只样本， 中证500指数更换50只样本，中证1000指数更换100只样本，中证A50指数更换4只样本，中证A100指数更换6只样本，中 证A500指数更换20只样本。 三人行首次公开发行股票募集资金总额为10.47亿元，募集资金净额9.88亿元。三人行于2020年4月23日披露的招股说明 书显示，募集资金净额将投资于以下项目：数字整合营销服务体系扩建项目、场景活动服务体系扩建项目、校园媒体扩 建项目、创意中心及业务总部建设项目、补充营运资金项目。 三人行首次公开发行股票的发行费用总计为5,843.97万元，其中，承销及保荐费用4,482.83万元。 三人行2024年年度报告显示，泰安众行为公司的员工持股平台。钱俊冬和崔蕾为夫妻关系，为公司的共同实际控制人 ...

Market Overview - The Shanghai Composite Index closed at 3928.73 points, above the annual line, with a gain of 0.66% [1] - The total trading volume of A-shares reached 16683.26 billion yuan [1] Stocks Breaking Annual Line - A total of 81 A-shares have surpassed the annual line today, with notable stocks including Tianli Composite, Wanshili, and Sanrenxing, showing divergence rates of 11.85%, 9.63%, and 9.17% respectively [1] - Stocks with smaller divergence rates that just crossed the annual line include Mingyang Electric, Meixin Technology, and Yinzhijie [1] Top Stocks by Divergence Rate - Tianli Composite (code: 920576) had a daily increase of 20.67% with a divergence rate of 11.85% [1] - Wanshili (code: 301066) increased by 10.08% with a divergence rate of 9.63% [1] - Sanrenxing (code: 605168) rose by 10.00% with a divergence rate of 9.17% [1] Additional Notable Stocks - Nanjing Shanglv (code: 600250) increased by 9.98% with a divergence rate of 8.18% [1] - Xiexin Integrated (code: 002506) rose by 9.96% with a divergence rate of 7.86% [1] - Daye Co. (code: 603278) increased by 9.98% with a divergence rate of 7.79% [1]

天眼查App显示，近日，悦酌三人行（宁夏）葡萄酒有限公司成立，法定代表人为高凯，注册资本100 万人民币，经营范围为许可项目：酒类经营；酒制品生产；食品互联网销售。（依法须经批准的项目， 经相关部门批准后方可开展经营活动，具体经营项目以相关部门批准文件或许可证件为准）一般项目： 水果种植；农作物栽培服务；广告制作；咨询策划服务；市场营销策划；项目策划与公关服务；技术服 务、技术开发、技术咨询、技术交流、技术转让、技术推广；体验式拓展活动及策划。（除依法须经批 准的项目外，凭营业执照依法自主开展经营活动）。 ...

Core Viewpoint - The announcement of a share transfer involving Sanrenxing (605168.SH) indicates a significant change in the company's shareholder structure, with Yan Jianya becoming the second-largest shareholder after acquiring approximately 16.87 million shares, representing 8% of the total share capital [2][4]. Group 1: Share Transfer Details - The share transfer price is set at 26.76 CNY per share, which is approximately 10% lower than the closing price on the trading day before the agreement [2]. - The total transaction value is approximately 451 million CNY [2]. - After the transfer, the combined shareholding of the controlling shareholders will decrease from 53.88% to 45.88%, while Qian Jundong and Cui Lei remain the actual controllers of the company [2]. Group 2: Yan Jianya's Background - Yan Jianya is a well-known entrepreneur and seasoned industry investor, currently serving as the chairman of Triangle Defense (300775.SZ) and the chairman of the board at Juzi Biotechnology (2367.HK) [3][4]. - His wealth reached 33 billion CNY in the 2025 Hurun Rich List, making him the new richest person in Shaanxi [3]. Group 3: Company Overview and Performance - Sanrenxing operates as a comprehensive advertising media company, focusing on integrated marketing services through various internet media resources [4]. - The company has faced declining performance, with projected revenues of 5.284 billion CNY and 4.208 billion CNY for 2023 and 2024, respectively, reflecting year-on-year decreases of 6.54% and 20.35% [6]. - For the first three quarters of the current year, the company reported revenues of 2.569 billion CNY, down 16.72% year-on-year, and a net profit of 144 million CNY, down 20.48% [7].

Group 1 - The core point of the article is that Yan Jianya and his wife, after becoming the richest individuals in Shaanxi, are initiating a new round of capital investment by acquiring an 8% stake in the marketing service company Sanrenxing for a total price of 450 million yuan [1] - Following the transaction, Yan Jianya will become the second-largest shareholder of Sanrenxing, with his shareholding only behind that of the controlling shareholder [1] - Yan Jianya and his wife, with a wealth of 45.7 billion yuan, topped the Hurun Rich List in October 2025, indicating their significant financial influence and diversified industrial layout across biotechnology, aerospace, and consumer sectors [1]

Core Viewpoint - The strategic acquisition of an 8% stake in Sanrenxing (605168.SH) by prominent investor Yan Jianya for a total price of 450 million yuan reflects a significant move to enhance industrial collaboration and optimize the company's equity structure [1][4][6]. Group 1: Transaction Details - Sanrenxing's controlling shareholder intends to transfer 8% of its shares to Yan Jianya, marking a pivotal shift in the company's ownership structure [1]. - Following the transaction, Yan Jianya will become the second-largest shareholder of Sanrenxing, just behind the controlling shareholder [4]. - The transaction is characterized as a strategic investment aimed at introducing a significant investor to improve the company's governance and operational framework [6]. Group 2: Background of Yan Jianya - Yan Jianya, recognized as the richest person in Shaanxi, has a diversified industrial portfolio that includes biotechnology and aerospace, with a wealth of 45.7 billion yuan as of October 2025 [5]. - His investment strategy is focused on creating a synergistic capital matrix in the A-share market, indicating a strategic intent to integrate industrial resources and enhance investment linkage [5][6]. Group 3: Previous Collaborations - Prior to this acquisition, Yan Jianya and Sanrenxing had established a collaborative relationship, with Yan's company, Juzhi Biotechnology, being both a client and an investment target for Sanrenxing [6]. - In November 2023, Sanrenxing successfully sold its shares in Juzhi Biotechnology for approximately 200 million yuan, yielding a profit of over 15 million yuan, showcasing the mutual trust between the two entities [6]. Group 4: Financial Performance - Sanrenxing has faced declining financial performance, with revenue projected to decrease from 5.653 billion yuan in 2022 to 4.208 billion yuan in 2024, and net profit dropping from 736 million yuan to 123 million yuan during the same period [8]. - The company's revenue and net profit for the first three quarters of 2025 were reported at 2.569 billion yuan and 144 million yuan, respectively, continuing the downward trend [8]. Group 5: Yan Jianya's Broader Investment Landscape - Yan Jianya's investment landscape includes significant stakes in listed companies such as Juzhi Biotechnology and Triangle Defense, which are foundational to his capital strategy [11]. - Juzhi Biotechnology has shown consistent high growth since its IPO in 2022, with projected revenues of 5.539 billion yuan and net profits of 4.547 billion yuan in 2024 [11]. - Triangle Defense, a key player in the aerospace sector, has maintained stable profitability, further solidifying Yan's investment base [11]. Group 6: Future Implications - The acquisition of Sanrenxing's shares by Yan Jianya is expected to lead to changes in the company's business direction and operational structure, which will be closely monitored [8].

Core Viewpoint - The article discusses the recent strategic investment by Yan Jianya, a newly crowned billionaire in Shaanxi, who acquired an 8% stake in the A-share integrated marketing service provider Sanrenxing for 450 million yuan, marking a significant move in his capital layout strategy [1][4][7]. Group 1: Investment Details - Sanrenxing's major shareholder and actual controller plans to transfer 8% of the company's shares to Yan Jianya for a total price of 450 million yuan [1][4]. - Following the transaction, Yan Jianya will become the second-largest shareholder of Sanrenxing, just behind the controlling shareholder [4] - The share transfer aims to introduce a significant strategic investor to optimize the shareholding structure of Sanrenxing [9]. Group 2: Background of Yan Jianya - Yan Jianya and his wife, Fan Daidi, topped the Hu Run Rich List in October 2025 with a wealth of 45.7 billion yuan, supported by their diversified industrial layout across biotechnology, aerospace, and consumer sectors [7]. - Their core capital foundation consists of two listed companies: Hong Kong's Juzhi Biotechnology and A-share Sanjiao Defense, with Juzhi being a leading player in collagen products [12][13]. Group 3: Strategic Implications - The investment reflects Yan Jianya's strategy to integrate industrial resources and strengthen investment and financing connections, providing insights into the operational logic of a "billionaire-level" investor [7][9]. - Prior to this investment, there were multiple collaborations between Yan Jianya's Juzhi Biotechnology and Sanrenxing, indicating a pre-existing trust and business relationship [9][10]. - The transaction is expected to influence Sanrenxing's internal business direction and operational structure, which has been under pressure with declining revenues and profits from 2022 to 2024 [10]. Group 4: Broader Capital Landscape - Yan Jianya's investment activities extend beyond listed companies, with significant investments in various aerospace and new materials companies, forming a comprehensive investment landscape across consumer, military, and marketing sectors [17]. - His private equity firm, Sanyuan Capital, manages funds focused on aerospace, new materials, and advanced manufacturing, further solidifying his influence in these industries [17].

Core Viewpoint - The recent acquisition of an 8% stake in the marketing service company Sanrenxing (605168.SH) by prominent investor Yan Jianya for 450 million yuan marks a strategic move in his capital layout, reflecting his intent to strengthen industrial resource integration and investment linkage [2][3]. Group 1: Investment Details - Yan Jianya will become the second-largest shareholder of Sanrenxing after the transaction, which is significant for his involvement in the company's governance [3]. - The share transfer aims to introduce a strategic investor to optimize the equity structure of Sanrenxing [3]. - Prior to this acquisition, Yan Jianya's company, Juzhi Biotechnology, had been a client and investment target of Sanrenxing, indicating a history of collaboration [5]. Group 2: Financial Performance - Sanrenxing's revenue has been under pressure, decreasing from 56.53 billion yuan in 2022 to 42.08 billion yuan in 2024, with net profit dropping from 7.36 billion yuan to 1.23 billion yuan during the same period [8]. - In the first three quarters of 2025, Sanrenxing reported revenues of 25.69 billion yuan and a net profit of 1.44 billion yuan, continuing the downward trend [8]. Group 3: Yan Jianya's Capital Landscape - Yan Jianya and his wife, Fan Daidi, have a diversified capital layout centered around Juzhi Biotechnology and Triangle Defense, spanning sectors like biotechnology, aerospace, and consumer goods [3][11]. - Juzhi Biotechnology, known as the "first stock of collagen," has shown continuous high growth, with projected revenues of 55.39 billion yuan and net profits of 45.47 billion yuan in 2024 [11]. - Triangle Defense, a core supplier in aerospace forging, reached a profit peak in 2023, maintaining stable profitability [12]. Group 4: Broader Investment Strategy - Yan Jianya's investment strategy includes a systematic approach to investing in related industrial chains, with significant stakes in both listed and unlisted companies [14][15]. - His private equity firm, Sanyuan Capital, focuses on sectors such as aerospace, new materials, and advanced manufacturing, managing funds between 1 to 2 billion yuan [14]. - Yan Jianya has also invested in various aerospace and new materials companies, further expanding his investment footprint across multiple sectors [15].

Core Viewpoint - The recent acquisition of an 8% stake in the marketing service provider Sanrenxing (605168.SH) by prominent investor Yan Jianya marks a strategic move to enhance his capital matrix and strengthen industry resource integration [1][2]. Group 1: Investment and Shareholding - Yan Jianya will become the second-largest shareholder of Sanrenxing after acquiring the shares for a total price of 450 million yuan [1]. - The share transfer aims to introduce a significant strategic investor to optimize the shareholding structure of Sanrenxing [2]. - Prior to this acquisition, Yan Jianya and Sanrenxing had multiple collaborations, including Sanrenxing's successful exit from an investment in Yan's company, Juzhi Biotechnology, yielding a profit of over 15 million yuan [2]. Group 2: Business and Financial Performance - Sanrenxing has faced continuous revenue pressure, with projected revenue declining from 5.653 billion yuan in 2022 to 4.208 billion yuan in 2024, and net profit dropping from 736 million yuan to 123 million yuan during the same period [5]. - In the first three quarters of 2025, Sanrenxing reported revenue of 2.569 billion yuan and a net profit of 144 million yuan, continuing the downward trend [5]. Group 3: Yan Jianya's Broader Capital Strategy - Yan Jianya's capital strategy is supported by his control over two listed companies: Juzhi Biotechnology and Triangle Defense (300775), which form the core of his capital base [6][7]. - Juzhi Biotechnology, known as the "first stock of collagen," has shown consistent high growth, with projected revenue of 5.539 billion yuan and net profit of 4.547 billion yuan in 2024 [6]. - Triangle Defense has maintained stable profitability, reaching a peak in earnings in 2023, and is a key supplier in the aerospace sector [6][7]. Group 4: Investment Landscape and Future Prospects - Yan Jianya's ambitions extend beyond listed companies, with investments in various sectors including consumer goods and military industry, aiming for a systematic investment layout around related industrial chains [10][13]. - His private equity firm, Sanyuan Capital, manages funds focused on aerospace, new materials, and advanced manufacturing, with a scale of 1 to 2 billion yuan [13]. - Yan Jianya has also invested in several aerospace and new materials companies, further diversifying his investment portfolio [13].